Xiamei Zhang

Author PubWeight™ 11.50^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.	J Bacteriol	2003	1.81
2	A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.	Cancer Res	2007	1.78
3	Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.	Cancer Res	2008	1.38
4	Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.	Antimicrob Agents Chemother	2002	1.34
5	Activity of and resistance to moxifloxacin in Staphylococcus aureus.	Antimicrob Agents Chemother	2003	1.30
6	SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model.	Arterioscler Thromb Vasc Biol	2008	1.26
7	Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.	Antimicrob Agents Chemother	2003	0.98
8	An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.	Anticancer Res	2009	0.92
9	The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models.	Cancer Biol Ther	2012	0.86